Department of Entomology, Kansas State University, Manhattan, KS, USA.
Institute of Applied Biology, Shanxi University, Taiyuan, China.
Pest Manag Sci. 2021 Feb;77(2):635-645. doi: 10.1002/ps.6114. Epub 2020 Oct 19.
Targeting insect-specific genes through post-transcriptional gene silencing with RNA interference (RNAi) is a new strategy for insect pest management. However, lepidopterans are recalcitrant to RNAi, which prevents application of novel RNAi technology to many notorious pests, including Ostrinia nubilalis (ECB). Strategies for enhancing RNAi efficiency, including large doses of double-stranded RNA (dsRNA), nuclease inhibitors, transfection reagents, and nanoparticles, have proved useful in other insects exhibiting substantial dsRNA degradation, a major mechanism limiting RNAi efficacy. To determine if similar strategies can enhance RNAi efficiency in ECB, various reagents were tested for their ability to enhance dsRNA stability in ECB tissues, then compared for their effectiveness in whole ECB.
Ex vivo incubation experiments revealed that Meta dsRNA lipoplexes, EDTA, chitosan-based dsRNA nanoparticles, and Zn enhanced dsRNA stability in ECB hemolymph and gut content extracts, compared with uncoated dsRNA. Despite these positive results, the reagents used in this study were ineffective at enhancing RNAi efficiency in ECB in vivo. To reduce assay time and required dsRNA, midguts were dissected and incubated in tissue culture medium containing dsRNA with and without reagents. These experiments showed that RNAi efficiency varied between target genes, and nuclease inhibitors improved RNAi efficiency for only a portion of the refractory target genes investigated ex vivo.
These results indicate that enhancing dsRNA stability is insufficient to improve RNAi efficiency in ECB and suggests the existence of additional, complex mechanisms contributing to low RNAi efficiency in ECB.
通过 RNA 干扰(RNAi)进行转录后基因沉默来靶向昆虫特异性基因是一种新的害虫管理策略。然而,鳞翅目昆虫对 RNAi 有抗性,这阻止了新型 RNAi 技术在许多臭名昭著的害虫中的应用,包括玉米螟(ECB)。增强 RNAi 效率的策略,包括双链 RNA(dsRNA)的大剂量、核酸酶抑制剂、转染试剂和纳米粒子,已被证明在其他表现出大量 dsRNA 降解的昆虫中是有效的,dsRNA 降解是限制 RNAi 效率的主要机制。为了确定类似的策略是否可以提高 ECB 中的 RNAi 效率,测试了各种试剂增强 ECB 组织中 dsRNA 稳定性的能力,然后比较了它们在整个 ECB 中的效果。
离体孵育实验表明,Meta dsRNA 脂质体、EDTA、壳聚糖基 dsRNA 纳米粒子和 Zn 与未涂层 dsRNA 相比,增强了 ECB 血淋巴和肠道内容物提取物中 dsRNA 的稳定性。尽管有这些积极的结果,但本研究中使用的试剂在体内增强 ECB 中的 RNAi 效率方面无效。为了减少测定时间和所需的 dsRNA,将中肠分离并在含有 dsRNA 的组织培养基中孵育,同时添加和不添加试剂。这些实验表明,RNAi 效率因靶基因而异,核酸酶抑制剂仅提高了部分体外研究的难治性靶基因的 RNAi 效率。
这些结果表明,增强 dsRNA 的稳定性不足以提高 ECB 中的 RNAi 效率,并表明存在其他复杂的机制导致 ECB 中的 RNAi 效率低。